NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP has filed a class action lawsuit in the United States District Court for the Eastern District of Michigan on behalf of current stockholders of Covisint Corporation(“Covisint” or the “Company”) (NASDAQGM: COVS) in connection with the planned acquisition of the company by OpenText (NASDAQ: OTEX).
On June 5, 2017, Covisint Corporation announced it had entered into an agreement in which OpenText, through its wholly owned subsidiary, Cypress Merger Sub, Inc., would acquire all outstanding shares of Covisint common stock for $2.45 per share. The lawsuit, entitled Keuning v. Covisint Corp., et al. (Case No. 2:17-cv-11958), alleges that defendants solicit stockholder votes in connection with the sale of the Company to OpenText through a proxy statement that omits material facts necessary to make the statements therein not false or misleading. Stockholders require this material information to make an informed vote.
If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2017. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Joseph E. Levi, at Levi & Korsinsky, LLP, (212) 363-7500, or via e-mail at firstname.lastname@example.org, or visit http://www.zlkdocs.com/COVS-Info-Request-Form-ma-5858. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice or may choose to do nothing and remain an absent class member.
A CLASS HAS NOT BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.